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Objectives: 5-Hydroxymethylfurfural (HMF) regularly occurs in foods and in alcoholic beverages. However, the risk of HMF associated with
alcohol consumption has not been systematically studied, so that this study will provide the first quantitative risk assessment of HMF for
consumers of alcoholic beverages.
Methods: Human dietary intake of HMF via alcoholic beverages in the European Union was estimated based on WHO alcohol consumption
data combined with our own survey data (n=944) and literature data (n=147) about the HMF contents of different beverage groups (beer,
wine, spirits and unrecorded alcohol). The risk assessment was conducted using the margin of exposure (MOE) approach.
Results: For olfactory epithelium metaplasia in female mice, a benchmark dose (BMD) of 127 mg/kg bodyweight (bw)/d and a BMD lower
confidence limit (BMDL) of 79 mg/kg bw/d were calculated from National Toxicology Program oral long-term animal experiments. The
average human exposure to HMF from alcoholic beverages was estimated at 6.0E-3 mg/kg bw/d, which is approximately 8.5% of the total
dietary exposure. In comparison of the human exposure with BMDL, the MOE was 13,167 for average alcohol consumption scenarios, which
is a value that would be generally assumed as safe for threshold based compounds.
Conclusions: The results show that the risk from HMF to the alcohol-consuming population is rather low and the priority for risk
management (e.g. to reduce the contamination) is also low. Further toxicological research about HMF is required to further elucidate its
mechanism. 
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INTRODUCTION
5-Hydroxymethylfurfural (HMF, C6H6O3, CAS No 67-47-
0) is a common product of the Maillard reaction and can be
found in many foods and beverages [1,2]. In particular, this
compound has been shown to be a good indicator for heat
processing of industrial manufactured foods [3]. The
toxicological relevance of HMF for humans is not yet fully
elucidated. At high concentrations that are not nutritionally
relevant, HMF is cytotoxic and causes irritation to the eyes,
the upper respiratory tract and the skin [4]. In the only
available long-term study by the National Toxicology
Program (NTP) in rats and mice, HMF did not demonstrate
any neoplastic effects in the intestinal tract [5]. Nevertheless,
an elevated incidence of hepatocellular adenoma and
carcinoma in the liver was observed in female mice [5]. 
Relatively high concentrations of HMF (exceeding 1 g/kg)
were found in some products such as dried fruits, caramel
products or instant coffee powder [1]. However, information
about the human daily dietary HMF exposure is scarce and
inconsistent. For example, Ulbricht et al. [4] estimated that
the HMF intake from food can reach 150 mg/person (p)/d,
while recent research showed a dietary intake of 27.6 mg/p/d
for the Norwegian population (95th percentile) [2] or 10
mg/p/d in the Spanish diet [6]. For Germany, the total HMF
intake was estimated in the 4 to 30 mg/p/d range [7]. It
should be noted that HMF consumption with alcoholic
beverages was not included in the German study because of
a lack of monitoring data [7]. In alcoholic beverages, HMF
was found, for example, in fortified wine (maximum 840
mg/L) [1], whiskey (maximum 55.9 mg/L) [8] or rum
(maximum 43.5 mg/L) [9]. Thus, the formation of HMF
from sugar dehydration or due to caramel color addition in
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alcohol products could be a potential problem.
In contrast to other constituents of alcoholic beverages
(e.g. higher alcohols or acetaldehyde), for which excellent
risk assessments have been published [10,11], we found a
major knowledge regarding the potential lack of public
health impact of HMF, resulting in an inability to
satisfactorily assess the risk for the consumers of the
alcoholic beverages researched. This study will therefore
give an overview about the HMF content of different kinds
of alcoholic beverages and, applying the harmonised
approach of the European Food Safety Authority (EFSA)
[12], we will provide a reliable human exposure estimate as
well as a risk assessment about HMF from alcohol
consumption.
MATERIALS AND METHODS
Data on HMF were obtained by a computer-assisted
literature search. Searches were carried out in the following
databases: PubMed (http://www.ncbi.nlm.nih.gov/sites/
entrez?db=pubmed), Toxnet (http://www.toxnet.nlm.nih.
gov/) and ChemIDplus (http://chem.sis.nlm.nih.gov/
chemidplus/), Web of Science (http://wokinfo.com/
products_tools/multidisciplinary/webofscience/) and
International Programme on Chemical Safety/Chemical
Safety Information from Intergovernmental Organizations
(http://www.inchem.org/). We specifically aimed to find
long-term animal studies that would be applicable for dose-
response modelling as well as studies about occurrence of
HMF in alcoholic beverages.
The data about HMF concentrations in alcoholic
beverages were obtained from the literature as well as from
our in-house analysis by means of nuclear magnetic
resonance (NMR) spectroscopy [13] and visible
spectroscopy using barbituric acid and para-toluidine for
derivatization [14]. The visible spectroscopic assay was
linear in a working concentration range of 1.7 to 60 mg/L
(R>0.99). The limit of detection (LOD) and limit of
quantification (LOQ) were 0.5 mg/L and 1.7 mg/L. For
authentic samples, the relative standard deviations (RSD)
were below 2%. Spiked recoveries were found to be 98% (at
5 mg/L) and 97% (at 20 mg/L). The NMR method was also
shown to provide adequate sensitivity with LOD of 2.0
mg/L and LOQ of 6.1 mg/L. The precision expressed as
RSD was around 4%, linearity was observed from 1 to 200
mg/L (r=0.99). The correlation between the results from
these two analytical techniques was significant (p<0.001), so
that all results could be combined to calculate the
distribution for the different beverage groups. 
Risk assessment analysis was conducted according to the
harmonised approach of the EFSA [12] and similar to our
previous acetaldehyde risk assessment [11]. This includes an
approach known as the margin of exposure (MOE). The
benchmark dose (BMD), derived from animal data by
mathematical dose-response modelling within the observed
range of experimental data, was used as a reference point. To
obtain the MOE, the benchmark dose lower confidence limit
(BMDL) for a 10% effect was calculated. The BMDL is an
estimate of the lowest dose that is 95% certain to cause no
more than a 10% effect (e.g. cancer incidence) in rodents.
The BMD and BMDL values were calculated using the US
Environmental Protection Agency’s BMD software version
2.2 (http:// www.epa.gov/ncea/bmds/index.html).
RESULTS
I. Toxicity of Orally Ingested HMF
There is no human study available, which would be
adequate for a risk assessment. There are some animal
experiments on HMF available in the literature. In the study
of Ulbricht et al. [4], rats were given 0, 40, 80 or 160 mg/kg
bodyweight (bw)/d HMF for 6 days a week over a period of
11 months. In the 160 mg/kg bw/d group, minor changes in
the clinical chemical parameters (globulin levels, hepatic
tributyrase) were revealed. Corpet et al. [15] examined a
tumour-inducing effect of HMF after initiation with
azoxymethane in CF1 mice and Fisher 344 rats which had
been given heat-treated sugar. Significantly higher number
of microadenomas of the intestines were observed after 100
days. The authors therefore concluded that heat-treatment
induced compounds promote colon cancer. However, the
actual role of HMF in this process was unclear. Another
study by the same research group revealed significantly
larger aberrant crypt foci (ACF, precursors of
microadenomas) in the group of rats fed with 1% HMF
compared to the control group [16]. In another study, where
rats were given 100 to 300 mg/kg bw/d HMF dissolved in
water, a dose-related increase was also observed in the
number of ACF [17]. 
A more reliable characterization of HMF toxicity and
carcinogenicity was recently conducted by NTP [5]. Male
and female F344/N rats and B6C3F1 mice were
administered HMF by gavage in deionised water for 3
weeks, 3 months or 2 years. In the three-week study 0 to
1,500 mg/kg bw/d doses were administered to mice and rats.
Although no chemical-related lesions were observed, the
final mean body weights of 1,500 mg/kg bw/day dose males
of both species were significantly less than those of the
vehicle control groups. In the 3-month study in rats
additional effects such as influences on oestrous cycles were
observed. Finally, groups of 50 male and female rats were
administered 0, 188, 375, or 750 mg/kg bw/d in deionised
water by gavage for 104 weeks. Survival of the dose groups
was greater than or similar to the control group. Mean body
weights of dosed groups of males and females were
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generally similar to those of controls throughout the study. In
750 mg/kg bw/d males, incidences of olfactory epithelium
degeneration were significantly increased as well as in 188
mg/kg bw/d and 375 mg/kg bw/d females. Incidences of
respiratory metaplasia and squamous metaplasia were
significantly increased in 750 mg/kg bw/d males and
females. Incidences of suppurative inflammation of the nose
and chronic active inflammation of the nasolacrimal duct
were increased in 750 mg/kg bw/d females. In the 104-week
study with mice with the same doses, significantly less
survival of 750 mg/kg bw/d males and females in
comparison with the vehicle control group was observed. In
the 750 mg/kg bw/d group, males and females exhibited
clinical signs indicative of neurological effects of HMF
administration. Importantly, the incidences of hepatocellular
adenoma were significantly increased in 188 and 375 mg/kg
bw/d females. The incidences of olfactory epithelium
metaplasia, degeneration in the nose as well as hyperplasia,
dilatation, and chronic active inflammation of the glands
were increased in 375 and 750 mg/kg bw/d males and
females [5].
The overall result of the NTP studies was classified as some
evidence of carcinogenic activity of HMF in female B6C3F1
mice based on elevated incidences of hepatocellular adenomas
(53% and 52% of total number of animals in the 188 mg/kg
bw/d and 375 mg/kg bw/d groups, respectively) [5].
II. Dose-response Analysis
From the animal experiments mentioned in the previous
section, only the two NTP long-term studies researching the
oral route of exposure to HMF appear to be suitable for
dose-response modelling for risk assessment purposes [5].
All end-points considered by NTP as related to the
administration of HMF [5] were selected for modelling. The
best-fitting significant models (own calculations) are listed in
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Table 1. Summary of own dose response modelling results for 5-hydroxymethylfurfural in different animal experiments
conducted by NTP [5]
BMDc
(mg/kg bw/d)
BMDLd
(mg/kg bw/d)p-value
bModelaSexEnd-point
Non-neoplastic effects 
Glands, dilatation (mice)
Glands, hyperplasia (mice)
Glands, inflammation, chronic active (mice)
Olfactory epithelium, accumulation, 
hyaline droplet (mice)
Olfactory epithelium, degeneration (mice)
Respiratory epithelium, metaplasia, squamous
(rats)
Olfactory epithelium, metaplasia (mice)
Olfactory epithelium, metaplasia (mice)
Neoplastic effects
Liver, hepatocellular adenoma (mice)
Without high doseg
Adjusted rateh
Adjusted rate, without high doseg,h
Liver, hepatocellular carcinoma (mice)
Without high doseg
Adjusted rateh
Adjusted rate, without high doseg,h
Hepatocellular adenoma or carcinoma (mice)
Without high doseg
Adjusted rateh
Adjusted rate, without high doseg,h
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Female
Female
Female
Female
Female
Female
Female
Female
Female
Female
Female
Female
Female
Log-logistic
Dichotomous-hill
Log-logistic
Dichotomous-hill
Probit
LogProbit
Gamma
Quantal-linear
Dichotomous-hill
Dichotomous-hill
Logistic
Logistic
Gamma
LogProbit
Weibull
Multistage
Multistage-cancer
Multistage
Multistage-cancer
Multistage-cancer
Weibull
Multistage
Weibull
Multistage
Multistage-cancer
Multistage
Multistage-cancer
(0.005)e
(0.646
(0.568
(1.0
(0.609
(0.831
(0.218
(0.0)e
(0.40
(0.0)e
(0.233
(0.0)e
(0.005)e
(0.042)e
(1.0
(0.767)f
(0.177
(0.695)f
(0.230
(0.805
(0.570
(0.777
(0.570
(0.560)f
(0.177
(0.621)f
(0.230
(50)
160)
143)
178)
205)
170)
117)
(101)
346)
(243)
157)
(171)
(138)
(165)
127)
42)
83)
(39)
74)
1,078)
427)
783)
427)
(44)
83)
(42)
74)
(42)
129)
99)
154)
165)
143)
79)
(80)
281)
(198)
124)
(143)
(95)
(121)
79)
27)
50)
(25)
46)
656)
380)
578)
380)
(28)
50)
(27)
46)
a Data from best-fitting models selected with BMD are presented.
b A p-value greater than 0.1 indicates that the model fits the data (p-value 1.0 = perfect fit).
c BMD: benchmark dose for a 10% incidence of health effect.
d BMDL: lower one-sided confidence limit of the BMD.
e Not significant dose-response. Values are shown in brackets for information.
f No clear dose-response as the highest dose-group had lower incidence than the control group 
g Calculation excluding 750 mg/kg bw/d group.
h The adjusted rate was modelled based on poly-3 estimated neoplasm incidence after adjustment for intercurrent mortality according to Table D2 of NTP [6].
Table 1. It can be seen that the values for different non-
neoplastic end-points calculated from the NTP study with
rats and mice are consistent with each other: the BMD and
BMDL values are in the range of 50 to 346 and 79 to 281
mg/kg bw/d, respectively. Overall the BMDs and BMDLs of
the models are in the same order of magnitude, which is
indicative of an overall adequacy of the calculated values, as
even between different models of the same end-point,
differences up to factors of 4 are accepted as typical, so that
an averaging of the values would be adequate [18]. The
modelling of neoplastic effects is more problematic as the
highest dose-group had lower incidence rate than the control
groups. For improved models for liver hepatocellular
adenoma and carcinoma, the high dose group may be
excluded from the calculation and the poly-3 estimated
neoplasm incidence after adjustment for intercurrent
mortality can be used (Table 1). Dropping the high dose
could be appropriate, because the lower response at the
higher dose could be due to a combination of early mortality
and a plateau in the level of a toxic metabolite due to
saturation of a metabolic process. According to NTP [5],
above 13 mg/kg bw/d, a significant increase in the furoic acid
metabolite of HMF relative to the glycine conjugate (which is
the predominant metabolite at lower concentrations) was
reported. At the highest dose administered (330 mg/kg bw/d
near the dose at which the tumour response plateaus), the
initial concentration of the furoic acid metabolite was 20- to
30-fold greater than the glycine conjugate. This may explain
the lower tumour response at very high doses if (a) the
glycine conjugate is a carcinogenic moiety whose body
burden has “levelled off” at high doses of HMF and/or (b)
the furoic acid metabolite is cytotoxic to the tumour cells
(i.e., acting as a chemotherapy agent) at high doses of HMF.
While this interpretation of the NTP data offers some
plausibility for neoplastic effects, the German Federal
Institute for Risk Assessment (Bundesinstitut für
Risikobewertung, BfR) remarked that it had doubts that
HMF has any carcinogenic potential [7]. The BfR based its
assessment on the fact that the tumours were only observed
in female mice, that B6C3F1 mice have a high spontaneous
tumour rate, and that no dose-response was proven. It is also
noteworthy that while the WHO International Agency for
Research on Cancer (IARC) does currently not provide an
evaluation of HMF, according to IARC criteria the evidence
for carcinogenicity of HMF appears to be inadequate
(sufficient evidence for animal experiments would require a
causal relationship in (a) two or more species of animals or
(b) two or more independent studies in one species. The
NTP itself judged that only “some evidence of carcinogenic
activity” was demonstrated, which means that the strength of
the response is less than that required for clear evidence [5].
We therefore judge the evidence about carcinogenicity as
too weak to be the basis for our risk assessment and
therefore use the non-neoplastic effects. To be conservative,
we decided to take the model with the lowest BMDL of all
significant non-neoplastic models for our further
calculations, which is the model for the olfactory epithelium
metaplasia in female mice with a BMD of 127 mg/kg bw/d
and a BMDL of 79 mg/kg bw/d (Figure 1). This BMDL is
also in the same order of magnitude to the BMDL tentatively
calculated for the neoplastic effects. Our values are well in
line with the assumption of the BfR that the threshold for
HMF effects in animals is iterating around 80 to 100 mg/kg
bw/d [7]. Notably, the values for HMF are less toxic than
what we calculated for acetaldehyde (BMD, 114 mg/kg
bw/d;  BMDL, 56 mg/kg bw/d) [11]. 
III. HMF Exposure from Alcohol Consumption
In this study we used the EFSA guidelines [12], which
recommend that risk assessments provide different exposure
scenarios (e.g. for entire, or specific groups of populations)
along with their inherent uncertainties. Other than the mean
and median, intakes from highly exposed individuals (due to
high consumption or to average consumption of highly
contaminated foods as represented by the 90th, 95th, 97.5th
and 99th percentiles) should be considered.
To provide estimates on the dietary intake of HMF, data
on the consumption of alcoholic beverages as well as their
content of HMF is needed. Currently systematic data are
lacking regarding HMF content of alcoholic beverages.
Although HMF is a typical component of heat-processed
foods [1], with the highest concentrations in balsamic
vinegar [19], coffee [20] and cereals [21], monitoring has
generally been sporadic and not consistent, especially
regarding alcoholic beverages.
Nevertheless, there are some studies where the actual
HMF content in different alcoholic beverages was
determined [1-3,6,8,9,22-36]. The investigation of alcoholic
beverages for HMF content started as early as 1948 with
measurement of cherry wines in which a maximum content
of 300 mg/L was observed [22]. In the following decades
HMF has been also detected in whiskey, rum, tequila and
other types of alcoholic beverages. However, in most of the
studies only limited numbers of samples were evaluated. 
Therefore, we provided our own HMF analysis of different
types of alcoholic beverages. The results for 944 samples are
shown in Table 2. The highest HMF concentration was
observed within fortified wines, which is also in agreement
with the literature [1,25,26]. Expectedly low concentrations
were obtained for beer (mean 1.6 mg/L), vodka (mean 2.1
mg/L) and fruit spirits (mean 2.8 mg/L). 
Furthermore, we combined our results of HMF occurrence
in alcoholic beverages with previously reported data (Table 3).
Table 3 shows the meta analysis as mean, median as well as
90th, 95th, 97.5th and 99th percentiles. When the HMF
values came from different studies, the values were obtained
by combination of all data available after proper
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transformation into the same unit (mg/L). Again, highly
variable concentrations were observed: mean concentrations
of HMF in a variety of alcoholic beverages ranged from 0.1
mg/L in wines to 296 mg/L in fortified wine. 
The annual consumption of different types of alcoholic
beverages for the population older than 15 can be easily
obtained from the WHO databases. This can be done for the
majority of the countries around the world. However, as
studies about HMF concentrations in alcoholic beverages
other than European-style beverages are lacking, we decided
to limit the whole population dietary intake estimate to the
European Union (EU). The HMF exposure due to alcoholic
beverage consumption was calculated from Table 3
combined with values of annual per capita consumption of
alcoholic beverages in the EU (see Lachenmeier et al. [11]
for details on annual consumption of the different beverage
groups). The average exposure was found to be about 0.006
mg/kg bw/d, while in a worst case of very high consumption
combined with very high concentrations in the beverages,
the exposure may reach up to 0.170 mg/kg bw/d. Table 4
summarizes the exposure for the different scenarios. 
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Table 3. 5-Hydroxymethylfurfural (HMF) concentration in alcoholic beverages
Mean Median 90thpercentile
95th
percentile
97.5th
percentile
99th
percentile
HMF (mg/L)
nData source
Beer
Wine
Fortified winea
Whiskey
White spirits 
Brandy
Rum/cane
Flavoured spirits
Unrecorded alcohol
The values are presented as meta-analysis combining own results from Table 2 with literature data.
a Not used for exposure estimation.
This study, [2], [33] 
This study, [28]
This study, [1]
This study, [3], [8] 
This study, [3], [8], [30]
This study, [8], [24], [32] 
This study, [8], [31] 
This study, [8], [24]
This study
1.7
0.1
2960.
8.6
2.2
220.
8.4
7.5
1.1
0.0
0.0
1290.
7.2
0.0
140.
3.3
0.0
0.0
4.8
0.2
8200.
170.
5.5
390.
250.
280.
3.7
5.7
0.6
8250.
220.
120.
480.
430.
530.
7.9
6.9
0.8
8300.
240.
280.
510.
440.
720.
110.
8.1
2.1
8300.
280.
290.
1220.
460.
860.
200.
292
038
011
068
075
045
114
162
286
Table 2. 5-Hydroxymethylfurfural (HMF) concentration in alcoholic beverages from 2009 to 2011
Mean Median 90thpercentile
95th
percentile
97.5th
percentile
99th
percentile Maximum
HMF (mg/L)
Positive
samples (%)nCategory
a
Rum
Whiskey
Vodkab
Tequila
Fruit spirits
Liqueurs
Brandy
Beer
Wine
Mulled wine
Fortified wine
Unrecorded alcohol
Total spirits
Total all alcoholic beverages
a The categories were primarily chosen based on available consumption data (see Lachenmeier et al. [11] for details).
b Including flavoured vodka.
022
064
049
012
124
027
026
288
026
012
008
286
324
944
590.
920.
100.
830.
170.
520.
880.
430.
3.9
500.
880.
120.
450.
340.
190.
8.7
2.1
6.0
2.8
210.
200.
1.6
0.0
190.
950.
1.1
7.2
3.8
160.
7.2
0.0
2.7
0.0
8.0
180.
0.0
0.0
5.0
320.
0.0
0.0
0.0
450.
180.
6.6
190.
6.9
650.
360.
4.8
0.0
330.
2670.
3.7
240.
110.
460.
230.
170.
240.
150.
720.
450.
5.7
0.0
860.
2710.
7.9
350.
230.
600.
240.
270.
260.
240.
760.
490.
6.8
1.1
1170.
2740.
110.
460.
360.
690.
290.
300.
260.
440.
800.
500.
7.4
2.1
1360.
2750.
200.
720.
570.
750.
350.
310.
270.
890.
830.
510.
140.
3.0
1480.
2760.
290.
890.
2760.
 
Figure 1. BMD modelling for HMF. Weibull model with 0.95
confidence level. BMD for a 10% incidence of health effect
(olfactory epithelium metaplasia, female mice, 104-week
study); BMDL: lower one-side confidence limit of the BMD.
BMD, benchmark dose; BMDL, benchmark dose lower
confidence limit; HMF, 5-hydroxymethylfurfural. Calculated
with data from NTP [5].
IV. Risk Characterization for the Alcohol-drinking
Population
The exposure data from Table 4 was used to characterize risk
using the MOE calculated from BMDL (Table 5). By risk
managers, MOEs can be used for setting priority, with a large
MOE representing a lower risk than a smaller one. Species
differences and human variability in the basic process of
toxicokinetics and toxicodynamics are inherent in the use of
data from studies in animals for human risk assessment. A
factor of 100-fold is usually used to allow for these uncertainties
in the risk assessment of non-genotoxic substances [12]. 
In the case of HMF, the MOEs were in some scenarios
below 1,000 but never below 100, demonstrating that in
general HMF in alcoholic beverages is not a public health
concern not even in worst-case scenarios. In comparison to
other constituents of alcoholic beverages, HMF also shows
lower potential risk. For example, the calculated MOE value
was 465 for HMF in the worst-case scenario (99th
percentile), which is of same order of magnitude as the
MOE value for average exposure to acetaldehyde from
alcoholic beverages [11,37]. A previous risk assessment of
HMF in food in general also showed a comparably low risk
of HMF for the average population [38]. It was estimated
that even in a worst case where up to 4.3 mg/kg bw of HMF
is consumed every day with beverages made from dried
plums, the margin of safety would still be of around 20 [38]. 
DISCUSSION
I. Limitations of the Approach 
In contrast to the risk assessment of another toxic
aldehyde - acetaldehyde - for which a considerably larger
database about human toxicity and genetic epidemiology
exists [11,39], our HMF assessment contains certain
limitations:
The assessment is based on only one oral animal study.
Additionally, there are no other estimates for BMDL and
BMD values in the literature. However, as the values
obtained for different end-points corresponded well to each
other, we believe that the chosen BMDL value is certainly in
the correct order of magnitude and could be used for
quantitative risk assessment. Uncertainty remains if a
carcinogenic effect exists and if it is non-threshold-based. In
that case, higher safety factors than 100 also would have to
be applied (but the average exposure would still be below an
MOE threshold of 10,000, which is typically applied to
carcinogens). Additionally, uncertainty remains regarding
the possibility of chronic toxic effects not studied by NTP
(such as some biochemical and haematological parameters)
which may show lower BMD than the neoplastic and non-
neoplastic effects. Finally, the absence of studies on
reproductive toxicity has to be considered [7]. 
We did not include fortified wine in our exposure
Environmental Health and Toxicology 2012; 27: e2012016
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Table 4. Exposure with 5-hydroxymethylfurfural (HMF) from alcoholic beverages
90th 
percentile
95th 
percentile
97.5th
percentile
99th 
percentile
Exposure scenarios for different HMF concentrations in the beverages 
MedianMean
HMF exposure
(mg/kg bw/d)
Exposure scenarios for different amounts of
alcoholic beverage consumption in Europe
Mean
Median
90th percentile
95th percentile
97.5th percentile
99th percentile
0.006
0.003
0.016
0.020
0.023
0.026
0.002
0.001
0.006
0.008
0.009
0.011
0.015
0.008
0.042
0.052
0.061
0.068
0.023
0.014
0.059
0.073
0.086
0.096
0.030
0.019
0.074
0.091
0.109
0.122
0.041
0.025
0.100
0.123
0.149
0.170
Table 5. Margin of Exposure (MOE) for 5-hydroxymethylfurfural (HMF) in different exposure scenarios
90th 
percentile
95th 
percentile
97.5th 
percentile
99th 
percentile
Exposure scenarios for different HMF concentrations in the beverages
MedianMean
MOE
Exposure scenarios for different amounts of
alcoholic beverage consumption in Europe
Mean
Median
90th percentile
95th percentile
97.5th percentile
99th percentile
13,167
26,333
04,938
03,950
03,435
03,038
39,500
79,000
13,167
09,875
08,778
07,182
5,267
9,875
1,881
1,519
1,295
1,162
3,435
5,643
1,339
1,082
0,919
0,823
2,633
4,158
1,068
0,868
0,725
0,648
1,927
3,160
0,790
0,642
0,530
0,465
The table shows the sum of all alcoholic beverages (beer, wine, spirits, unrecorded) calculated as mg/kg bw/d (calculated for a 60 kg person) 
Values are calculated with benchmark dose lower confidence limit (BMDL) of 79 mg/kg bw/d (MOE = BMDL/exposure).
estimations at all because of the limited number of samples
we have. Therefore, the whole evaluation may be under-
estimated because this group usually contains higher amount
of HMF than other types of alcoholic beverages (Tables 2
and 3). However, the population-based consumption of
fortified wine is very low. 
The data on exposure are still incomplete; especially data
on levels in fortified wine is scarce. Therefore, analytical
data on the concentrations of HMF in this beverage group
would be required for more reliable risk assessment,
especially for individual drinkers that prefer this beverage
group. 
II. Estimation of Total Dietary Exposure
Besides alcoholic beverages, humans could be exposed to
HMF from other sources. However, the current data only
allow rough estimations. HMF occurs in almost all heat-
processed foods in the concentrations ranging from trace
levels in juices to approximately 4,000 mg/kg in coffee. In a
study conducted in Spain, HMF exposure of the Spanish
population from heat processed food was estimated [6]. An
average HMF intake of 10 mg/p/d was obtained with coffee
and bread as the most important food items that contribute to
nearly 85% of daily exposure. In another study by Husoy et
al. [2], the 95th percentile of the estimated daily intake was
27.6 mg/p/d (0.46 mg/kg bw/d) for the Norwegian population
[2]. For Germany, HMF consumption with food was
estimated at 4.04 mg/p/d (mean exposure) and 12.87 mg/p/d
(95th percentile exposure) [7]. Based on these and our data
we can estimate the total exposure (from food and alcoholic
beverages) at 4.40 mg/p/d (mean exposure) and 14.7 mg/p/d
(95th percentile exposure) for the German population. Thus,
the average exposure via alcoholic beverages does not play
an important role and makes up only approximately 8.5% of
the total exposure according to our calculations. Nevertheless,
data on cumulative HMF exposure (especially for food and
beverages containing caramel colour) are sparse and should
be updated in the future.
III. Suggestions for Risk Management
For regulatory toxicology, it is important to know if an
agent has a threshold-based mechanism, which would allow
to define tolerable daily intakes. Although no-observed
adverse effect levels around 80 to 100 mg/kg bw/d were
suggested for HMF, it is currently impossible to estimate a
tolerable daily intake because of the limited mechanistic data
and especially the concerns for carcinogenicity [38]. 
Our conclusion is that the occurrence of HMF in alcoholic
beverages does not constitute an additional risk for average
drinkers. Our data showed that in typical scenarios, the HMF
exposure in alcoholic beverages (mean  0.006 mg/kg bw/d)
is very low relative to the hazard (BMDL  79 mg/kg bw/d)
and is therefore not a public health concern. For other
compounds of alcoholic beverages such as acetaldehyde or
ethyl carbamate, MOEs were in considerably lower ranges
[11,37] as our calculations for HMF. The major risk,
however, certainly comes from ethanol with a MOE of 1 or
even smaller [40]. Therefore, for the regulation of alcoholic
beverages, we do not consider HMF to be a high priority for
risk management measures (such as mitigative efforts to
reduce its content).
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